WT1 and glioblastoma: Peripheral blood mononuclear cells from 30 GBM patients prior to WT1 vaccination in a discovery set were subjected to cDNA microarray analysis, candidate genes that differentially expressed between long- and short-term survivors were selected, followed by verification with quantitative RT-PCR.